Knight Therapeutics Reports First Quarter 2024 Results
GlobeNewswire
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading..
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading..
The Chondroitin Sulfate Market Size was valued at USD 1.19 Billion in 2022 and the Global Chondroitin Sulfate Market is expected to..
JAKARTA, Indonesia, Aug. 30, 2023 /PRNewswire/ --* Bio Farma*, Indonesia's state-owned pharmaceutical company, has successfully..